Center-Authored Papers

Filters: Author is Disis, Mary L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Xenograft Model Antitumor Assays
Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem H-P, Disis ML et al..  2009.  Toward a stem cell gene therapy for breast cancer.. Blood. 113(22):5423-33. Abstract
Washington
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract
Vaccination
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
United States
Cheever MA, Schlom J, Weiner LM, Lyerly KH, Disis ML, Greenwood A, Grad O, Nelson WG.  2008.  Translational Research Working Group developmental pathway for immune response modifiers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(18):5692-9. Abstract
Treatment Outcome
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Translational Bioimaging Center Core Facility
Liao JB, Ovenell KJ, Curtis EEM, Cecil DL, Koehnlein MR, Rastetter LR, Gad EA, Disis ML.  2015.  Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer.. Journal for immunotherapy of cancer. 3:16. Abstract
Transforming Growth Factor beta
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Time Factors
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract
T-Lymphocytes, Regulatory
Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem H-P, Disis ML et al..  2009.  Toward a stem cell gene therapy for breast cancer.. Blood. 113(22):5423-33. Abstract
T-Lymphocytes
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM, Disis ML.  2009.  Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.. Breast cancer research and treatment. 113(1):95-100. Abstract
Survival Rate
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract
Survival Analysis
Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem H-P, Disis ML et al..  2009.  Toward a stem cell gene therapy for breast cancer.. Blood. 113(22):5423-33. Abstract
Stromal Cells
Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem H-P, Disis ML et al..  2009.  Toward a stem cell gene therapy for breast cancer.. Blood. 113(22):5423-33. Abstract
Specimen Processing Core Facility
Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT et al..  2014.  Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.. Cancer immunology research. 2(11):1071-9. Abstract
Software Design
Cheever MA, Schlom J, Weiner LM, Lyerly KH, Disis ML, Greenwood A, Grad O, Nelson WG.  2008.  Translational Research Working Group developmental pathway for immune response modifiers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(18):5692-9. Abstract
Skin Neoplasms
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract
Shared Resources
Disis ML, Dang Y, Coveler AL, Marzbani E, Kou ZC, Childs JS, Fintak P, Higgins DM, Reichow J, Waisman J et al..  2014.  HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.. Cancer immunology, immunotherapy : CII. 63(2):101-9. Abstract
Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM, Disis ML.  2009.  Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.. Breast cancer research and treatment. 113(1):95-100. Abstract
Amon LM, Pitteri SJ, Li CI, McIntosh MW, Ladd J, Disis ML, Porter PL, Wong C-H, Zhang Q, Prentice RL et al..  2012.  Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.. Cancer research. Abstract
Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML.  2012.  Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera.. Cancer prevention research (Philadelphia, Pa.). Abstract
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Cecil DL, Holt GE, Park KH, Gad E, Rastetter L, Childs J, Higgins D, Disis ML.  2014.  Elimination of IL-10-Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity.. Cancer research. 74(10):2710-8. Abstract
Scientific Imaging Core Facility
Katayama H, Boldt C, Ladd JJ, Johnson MM, Chao T, Capello M, Suo J, Mao J, Manson JE, Prentice R et al..  2015.  An autoimmune response signature associated with the development of triple negative breast cancer reflects disease pathogenesis.. Cancer research. 75(16):3246-54. Abstract
Risk Factors
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract